MC38-B2m KO
Strain Information
Validation Data
Fig1. Detection of B2M expression on in vitro cultured cells of MC38-B2M-KO cell line by FACS.
Fig2. Detection of B2M expression on in vitro cultured cells of MC38-B2M-KO cell line by WB.
Fig3. In vivo validation of MC38-B2M-KO cells in C57BL/6 mice (n=6).
C57BL/6 mice were inoculated with MC38-B2M-KO subcutaneously at 1×106 cells/mouse inoculum for tumor development.
Fig4. B2M expression in tumors after in vivo growth of MC38-B2M-KO in wild type C57BL/6 mice
The tumors were collected at day 18 post tumor cell inoculation.
Related Strain(s)
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
